Last Updated: June 17, 2026

Litigation Details for Shire LLC v. Abhai LLC (D. Mass. 2015)


✉ Email this page to a colleague

« Back to Dashboard


Shire LLC v. Abhai LLC (D. Mass. 2015)

Docket 1:15-cv-13909 Date Filed 2015-11-20
Court District Court, D. Massachusetts Date Terminated 2018-03-22
Cause 15:1126 Patent Infringement Assigned To William G. Young
Jury Demand None Referred To
Patents 6,322,819; 6,605,300; RE41,148; RE42,096
Link to Docket External link to docket
Small Molecule Drugs cited in Shire LLC v. Abhai LLC
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial and ⤷  Start Trial .

Details for Shire LLC v. Abhai LLC (D. Mass. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-11-20 External link to document
2015-11-20 1 System,” is a reissue of U.S. Patent. No. 6,322,819 (“the ’819 Patent”), which issued on November 27,…States Reissued Patent Nos. RE42,096 (“the ’096 Patent”) and RE41,148 (“the ’148 Patent”). Shire seeks… 1. This action for patent infringement, brought pursuant to the patent laws of the United States…. This civil action for patent infringement arises under the patent laws of the United States, including…and alleges infringement of the ’096 Patent and the ’148 Patent. This Court has jurisdiction over the External link to document
2015-11-20 337 reissue of U.S. Patent No. 6,322,819 (the “‘819 Patent’”). Id. at ¶ 22. The ‘819 Patent was issued …), for patent infringement of the United States Reissued Patent No. RE42,096 (the “‘096 Patent”), in…, and patent infringement of the United States Reissued Patent No. RE41,148 (the “‘148 Patent”) in violation… Id. The ‘148 Patent is a reissue of U.S. Patent No. 6,605,300 (the “‘300 Patent”). Id…the 096 Patent and Claims 1, 11 (as it depends from Claim s 1, 2, and 7), and 13 of the 148 Patent. Abhai External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Litigation summary and analysis for: Shire LLC v. Abhai LLC (D. Mass. 2015)

Last updated: June 12, 2026

Shire LLC v. Abhai LLC 1:15-cv-13909: Litigation Summary, Claims at Issue, and IP-Strength Takeaways

Shire LLC sued Abhai LLC in the US District Court for the District of Massachusetts under case number 1:15-cv-13909. The record is not provided here, and the decision history, asserted patents, claim constructions, infringement theories, defenses, and settlement/termination posture are not supplied. Without the docket text and case filings, a complete, accurate litigation summary and analysis cannot be produced.

What is the docket history for Shire LLC v. Abhai LLC 1:15-cv-13909?

No case timeline can be stated because the docket events (complaint filing date, service, motions, claim construction, summary judgment, trial, and final judgment/termination) are not included.

What were the key procedural milestones (complaint, MTC, Markman, summary judgment, final judgment)?

No milestone dates or rulings are available from the provided information.

Did the court decide any claim construction or dispositive motions?

No claim construction or dispositive outcomes are provided.


Which patents did Shire assert in Shire LLC v. Abhai LLC 1:15-cv-13909?

The asserted patent list and asserted claims are not included. Without patent numbers and claim groupings, infringement scope and validity exposure cannot be analyzed.

What were the infringement theories (composition, method of use, formulation, process/manufacturing)?

No asserted theories are provided.

What were Abhai’s defenses (noninfringement, invalidity, unenforceability, prosecution history estoppel)?

No defense details are provided.


How did the court treat the asserted claims and claim scope in Shire LLC v. Abhai LLC?

No Markman order, claim construction language, or infringement analysis is available.

What claim terms were construed and how did construction affect the case?

No construction information is provided.

Were any claims held not infringed or invalid at summary judgment?

No summary-judgment holdings are provided.


What is the litigation outcome and status for Shire LLC v. Abhai LLC?

No dispositive outcome is included (dismissal, settlement, consent judgment, default, summary judgment, or trial verdict).

Was there a settlement, consent judgment, or ongoing injunction?

No settlement or enforcement terms are provided.

Has the case been terminated, and what was the termination date?

No termination data is provided.


How strong is the Shire patent estate relative to Abhai’s product exposure in 1:15-cv-13909?

No product-identification, labeling, ANDA/BLA posture, or asserted-claim mapping is provided. Without that, patent-strength analysis is not possible.

What generic or competing product was at issue and what FDA pathway did it use?

No FDA pathway or product information is provided.

Were Paragraph IV challenges involved and did any Hatch-Waxman exclusivity drive the case?

No Hatch-Waxman details are provided.


What patent infringement risks does this case create for Abhai or other entrants?

No holdings or even asserted claim scope is available, so risk quantification cannot be stated.

What injunction or design-around guidance emerged from the litigation?

No injunction language or guidance is provided.

Did the case identify manufacturing, formulation, or process barriers?

No manufacturing/process findings are provided.


Key Takeaways

  • A litigation summary and analysis for Shire LLC v. Abhai LLC (1:15-cv-13909) cannot be produced from the information provided, because the docket history, asserted patents, claim constructions, rulings, and outcome are not included.

FAQs

  1. What patents were asserted in Shire LLC v. Abhai LLC (1:15-cv-13909)?
    Not provided.

  2. Did the court issue a Markman (claim construction) order in 1:15-cv-13909?
    Not provided.

  3. What was the final disposition of the case (settlement, dismissal, judgment)?
    Not provided.

  4. Were any Hatch-Waxman Paragraph IV allegations tied to the asserted patents?
    Not provided.

  5. Does the case mention an Orange Book listing or FDA approval tied to the dispute?
    Not provided.

References

No sources cited because no case record details were provided.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.